Cognition TherapeuticsCGTX
13F holders, Q3 2024 (September 30)40holders −6
9new positions
14sold out
1famous investor
$0.47avg. 13F price*
At the end of Q3 2024, 40 institutions reported holding Cognition Therapeutics Inc. (CGTX) in their 13F filings, down 6 from Q2 2024. 9 opened new positions and 14 sold out. The largest holders were Vanguard Group Inc. ($583K), Alyeska Investment Group, L.P. ($234K) and Geode Capital Management, LLC ($152K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cognition Therapeutics Inc.
- CUSIP
- 19243B102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $212K |
| Exits | 14 | $2.7M |
All 13F filers, Q2 2024 → Q3 2024: 706,154 shares bought and 1,747,066 shares sold, net −1,040,912 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Vanguard Group Inc. | 0.00% | Add +8.3% | 1,242,554 | $583K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 500,000 | $234K |
| Geode Capital Management, LLC | 0.00% | Add +32.2% | 323,643 | $152K |
| CM Management, LLC | 0.09% | Add +25.0% | 250,000 | $117K |
| American Financial Group Inc. | 0.04% | No change | 205,000 | $96K |
| UBS Group AG | 0.00% | New | 197,859 | $93K |
| Sigma Planning Corp | 0.00% | Add +14.6% | 197,190 | $92K |
| Kestra Advisory Services, LLC | 0.00% | No change | 188,434 | $88K |
| BlackRock, Inc. | 0.00% | — | 155,545 | $73K |
| Acadian Asset Management LLC | 0.00% | New | 140,943 | $64K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 90,665 | $42K |
| Renaissance Technologies | 0.00% | Reduce -1.1% | 88,700 | $42K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 76,700 | $36K |
| State Street Corp. | 0.00% | No change | 62,750 | $29K |
| Virtu Financial LLC | 0.00% | New | 57,231 | $27K |
| Texas Capital Bank Wealth Management Services Inc | 0.00% | No change | 55,395 | $26K |
| Fca Corp. | 0.01% | No change | 51,471 | $24K |
| Circle Wealth Management, LLC | 0.00% | No change | 48,842 | $23K |
| Northern Trust Corp. | 0.00% | No change | 47,485 | $22K |
| Castle Wealth Management LLC | 0.01% | No change | 43,380 | $20K |
| Bangor Savings Bank | 0.00% | No change | 34,019 | $16K |
| Northeast Financial Consultants Inc | 0.00% | No change | 24,500 | $11K |
| Tocqueville Asset Management L.P. | 0.00% | Reduce -41.3% | 23,500 | $11K |
| HighTower Advisors, LLC | 0.00% | No change | 22,962 | $11K |
| Jane Street Group, LLC | 0.00% | New | 22,730 | $11K |
| Mercer Global Advisors Inc. | 0.00% | Reduce -83.3% | 16,051 | $7K |
| Bessemer Group Inc. | 0.00% | New | 13,797 | $6K |
| Smith Anglin Financial, LLC | 0.00% | No change | 12,000 | $6K |
| Two Sigma Investments, LP | 0.00% | New | 11,370 | $5K |
| Two Sigma Advisers, LP | 0.00% | New | 11,000 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3.4% | 10,990 | $5K |
| Raymond James & Associates | 0.00% | No change | 10,000 | $5K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 5,867 | $3K |
| Bank of America Corp. | 0.00% | Add +1.2% | 5,279 | $2K |
| Bray Capital Advisors | 0.00% | No change | 2,250 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 1,800 | $846 |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $469 |
| Morgan Stanley | 0.00% | Reduce -66.7% | 1,000 | $469 |
| JPMorgan Chase & Co. | 0.00% | New | 78 | $37 |
| FMR LLC | 0.00% | Reduce -99.0% | 1 | $0 |
"% of holder's portfolio" is CGTX's weight in each manager's 13F, not the share of Cognition Therapeutics Inc. the manager owns.